Abstract:ABSTRACT Bacteria and their viral predators (phages) are constantly evolving to subvert one another. Many bacterial immune systems that inhibit phages are encoded on mobile genetic elements that can be horizontally transmitted to diverse bacteria. Despite the pervasive appearance of immune systems in bacteria, it is not often known if these immune systems function against phages that the host encounters in nature. Additionally, there are limited examples demonstrating how these phages counter-adapt to such immune systems. Here, we identify clinical isolates of the global pathogen Vibrio cholerae harboring a novel genetic element encoding the bacterial immune system DarTG and reveal the immune system’s impact on the co-circulating lytic phage ICP1. We show that DarTG inhibits ICP1 genome replication, thus preventing ICP1 plaquing. We further characterize the conflict between DarTG-mediated defense and ICP1 by identifying an ICP1-encoded protein that counters DarTG and allows ICP1 progeny production. Finally, we identify this protein, AdfB, as a functional antitoxin that abrogates the toxin DarT likely through direct interactions. Following the detection of the DarTG system in clinical V. cholerae isolates, we observed a rise in ICP1 isolates with the functional antitoxin. These data highlight the use of surveillance of V. cholerae and its lytic phages to understand the co-evolutionary arms race between bacteria and their phages in nature. IMPORTANCE The global bacterial pathogen Vibrio cholerae causes an estimated 1 to 4 million cases of cholera each year. Thus, studying the factors that influence its persistence as a pathogen is of great importance. One such influence is the lytic phage ICP1, as once infected by ICP1, V. cholerae is destroyed. To date, we have observed that the phage ICP1 shapes V. cholerae evolution through the flux of anti-phage bacterial immune systems. Here, we probe clinical V. cholerae isolates for novel anti-phage immune systems that can inhibit ICP1 and discover the toxin-antitoxin system DarTG as a potent inhibitor. Our results underscore the importance of V. cholerae and ICP1 surveillance to elaborate novel means by which V. cholerae can persist in both the human host and aquatic reservoir in the face of ICP1.

Phages carry orphan antitoxin-like enzymes to neutralize the DarTG1 toxin-antitoxin defense system

The DarTG toxin-antitoxin system provides phage defense by ADP-ribosylating viral DNA

A phage-encoded counter-defense inhibits an NAD-degrading anti-phage defense system

Specificity of DNA ADP-Ribosylation Reversal by NADARs

Toxic anti-phage defense proteins inhibited by intragenic antitoxin proteins

Sporadic phage defense in epidemic Vibrio cholerae mediated by the toxin-antitoxin system DarTG is countered by a phage-encoded antitoxin mimic

Phages reconstitute NAD to counter bacterial immunity

Molecular basis for DarT ADP-ribosylation of a DNA base

Phages reconstitute NAD + to counter bacterial immunity

Bacteria renew an OLD protein to cleave host tRNAs and block phage translation

Bacteriophage antidefense genes that neutralize TIR and STING immune responses

Anti-viral defense by an ADP-ribosyltransferase that targets mRNA to block translation

Retron-Eco1 assembles NAD + -hydrolyzing filaments that provide immunity against bacteriophages

Structural and functional evidence of bacterial antiphage protection by Thoeris defense system via NAD+ degradation

Pervasive phosphorylation by phage T7 kinase disarms bacterial defenses

Mechanism of phage sensing and restriction by toxin-antitoxin-chaperone systems

Systematic Discovery of Phage Genes that Inactivate Bacterial Immune Systems

Phage defence by deaminase-mediated depletion of deoxynucleotides in bacteria.

TARG1 protects against toxic DNA ADP-ribosylation

DNA glycosylases provide antiviral defence in prokaryotes

Anti-viral defence by an mRNA ADP-ribosyltransferase that blocks translation